Design Therapeutics, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €130.42K
    Gross profit
    -€130.42K
    SG&A expenses
    €16.97M
    R&D expenses
    €47.32M
    EBITDA
    -€63.89M
    D&A
    €525.95K
    EBIT
    -€64.29M
    Interest expenses
    €0.00
    EBT
    -€54.47M
    Tax expenses
    €0.00
    Net income
    -€54.47M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €1.96M
    Changes in working capital
    €2.21M
    Operating cash flow
    -€43.45M
    Capex
    €122.69K
    Other investing cash flow
    €0.00
    Net investing cash flow
    €20.59M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    -€213.64K
    Debt repayment
    €0.00
    Other financing cash flow
    €246.25K
    Net financing cash flow
    €555.98K
    Foreign exchange effects
    €0.00
    Net change in cash
    -€22.30M
    Cash at end of period
    €16.91M
    Free cash flow
    -€43.32M

    Balance sheet

    Cash and cash equivalents
    €16.91M
    Cash and short-term investments
    €185.56M
    Total receivables
    €1.16M
    Inventory
    €0.00
    Other current assets
    €1.86M
    Total current assets
    €188.58M
    Property, plant & equipment
    €2.65M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €2.65M
    Total assets
    €191.24M
    Accounts payable
    €869.15K
    Short-term debt
    €724.15K
    Other current liabilities
    €5.91M
    Total current liabilities
    €7.50M
    Long-term debt
    €1.89M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €945.52K
    Total liabilities
    €8.45M
    Common stock
    €5.15K
    Retained earnings
    -€226.52M
    Other equity
    €261.69K
    Total equity
    €182.79M
    Total liabilities and shareholders' equity
    €191.24M

    Company information

    Market capitalization
    €172.86M
    Employees
    56
    Enterprise Value
    €209.87M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -29.8% Much worse than peer group: 8.1%
    ROA
    -28.5% Much better than peer group: -762.9%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -25.2%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€972.73K

    Notifications